1 mg semaglutide – SpringCare Clinic Semaglutide Weight Loss FAQs: Everything

A Novo Nordisk spokesperson pointed out that NAION is not listed on approved labels as an adverse drug reaction for the marketed formulations of semaglutide. They also noted limitations in the Mass Eye and Ear study, such as its small and non-randomized sample group

It is also noteworthy that central GLP-1R signaling appears to be impaired in chronic stress conditions or under the influence of a high concentration of glucocorticoids, often observed in patients with depression

Kanduri SR, Kovacic R, Skipper GR, Velez JCQ

Your prescribing provider or Strive customer service can confirm state-specific availability